Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
2件: PML, RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
2 Adherens junction 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
3 Adherens junction 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
4 Adipocytokine signaling pathway 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
5 Adipocytokine signaling pathway 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
6 Adipocytokine signaling pathway 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
7 Adipocytokine signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
8 African trypanosomiasis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
10 Alcoholic liver disease 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
11 Alcoholic liver disease 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
12 Alcoholic liver disease 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
13 Alcoholic liver disease 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
14 Allograft rejection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
15 Alzheimer disease 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
16 Amoebiasis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
17 AMPK signaling pathway 💬
1件: HMGCR 💬 Rosuvastatin calcium 💬 Rosuvastatin 13件:  6 , 18, 46, 49, 51, 56, 65, 79, 94, 96, 97, 271, 299 💬
18 AMPK signaling pathway 💬
1件: HMGCR 💬 Rosuvastatin 💬 Rosuvastatin 13件:  6 , 18, 46, 49, 51, 56, 65, 79, 94, 96, 97, 271, 299 💬
19 AMPK signaling pathway 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
20 AMPK signaling pathway 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
21 AMPK signaling pathway 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
22 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
23 Antigen processing and presentation 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
24 Apoptosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
25 Arrhythmogenic right ventricular cardiomyopathy 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
26 Arrhythmogenic right ventricular cardiomyopathy 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
27 Asthma 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
28 Axon guidance 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
29 Bacterial invasion of epithelial cells 💬
2件: ITGA5, ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
30 Bile secretion 💬
1件: HMGCR 💬 Rosuvastatin calcium 💬 Rosuvastatin 13件:  6 , 18, 46, 49, 51, 56, 65, 79, 94, 96, 97, 271, 299 💬
31 Bile secretion 💬
1件: HMGCR 💬 Rosuvastatin 💬 Rosuvastatin 13件:  6 , 18, 46, 49, 51, 56, 65, 79, 94, 96, 97, 271, 299 💬
32 Bile secretion 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
33 Bile secretion 💬
1件: NR1H4 💬 Ursodiol 💬 Ursodeoxycholic acid 14件:  6 ,  8 , 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬
34 Bladder cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
35 Bladder cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
36 Breast cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
37 Breast cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
38 Breast cancer 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
39 C-type lectin receptor signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
40 Calcium signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
41 Calcium signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
42 Calcium signaling pathway 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
43 cAMP signaling pathway 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
44 cAMP signaling pathway 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
45 cAMP signaling pathway 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
46 Cell adhesion molecules 💬
1件: CD2 💬 Siplizumab 💬 Siplizumab 2件: 94, 95 💬
47 Cell adhesion molecules 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
48 Cell adhesion molecules 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
49 Central carbon metabolism in cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
50 Central carbon metabolism in cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
51 Chagas disease 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
52 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
53 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
54 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
55 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
56 Chemical carcinogenesis - receptor activation 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
57 Chemical carcinogenesis - receptor activation 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
58 Chemical carcinogenesis - receptor activation 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
59 Chemokine signaling pathway 💬
2件: CCR2, CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
60 Chemokine signaling pathway 💬
2件: CCR2, CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
61 Choline metabolism in cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
62 Choline metabolism in cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
63 Colorectal cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
64 Colorectal cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
65 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
66 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
67 Coronavirus disease - COVID-19 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
68 Cushing syndrome 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
69 Cushing syndrome 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
70 Cytokine-cytokine receptor interaction 💬
2件: CCR2, CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
71 Cytokine-cytokine receptor interaction 💬
2件: CCR2, CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
72 Cytokine-cytokine receptor interaction 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
73 Cytoskeleton in muscle cells 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
74 Cytoskeleton in muscle cells 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
75 Diabetic cardiomyopathy 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
76 Diabetic cardiomyopathy 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
77 Diabetic cardiomyopathy 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
78 Dilated cardiomyopathy 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
79 Dilated cardiomyopathy 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
80 Dilated cardiomyopathy 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
81 Drug metabolism - other enzymes 💬
2件: IMPDH, IMPDH 💬 Mizoribine 💬 Mizoribine 8件: 46, 49, 51, 53, 66, 94, 222, 224 💬
82 Drug metabolism - other enzymes 💬
1件: RRM1 💬 Cladribine 💬 Cladribine 3件: 11, 13, 94 💬
83 ECM-receptor interaction 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
84 ECM-receptor interaction 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
85 Efferocytosis 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
86 Efferocytosis 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
87 Endocytosis 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
88 Endocytosis 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
89 Endocytosis 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
90 Endocytosis 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
91 Endocytosis 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
92 Endometrial cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
93 Endometrial cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
94 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
95 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
96 Epstein-Barr virus infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
97 ErbB signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
98 ErbB signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
99 Estrogen signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
100 Estrogen signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
101 Estrogen signaling pathway 💬
1件: RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
102 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
103 Fluid shear stress and atherosclerosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
104 Focal adhesion 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
105 Focal adhesion 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
106 Focal adhesion 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
107 Focal adhesion 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
108 Folate transport and metabolism 💬
1件: thyA 💬 Capecitabine 💬 Capecitabine 1件: 94 💬
109 FoxO signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
110 FoxO signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
111 Gap junction 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
112 Gap junction 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
113 Gastric cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
114 Gastric cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
115 Gastric cancer 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
116 Gastric cancer 💬
1件: RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
117 Glioma 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
118 Glioma 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
119 Glucagon signaling pathway 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
120 Glucagon signaling pathway 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
121 Glucagon signaling pathway 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
122 Glutathione metabolism 💬
1件: RRM1 💬 Cladribine 💬 Cladribine 3件: 11, 13, 94 💬
123 GnRH signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
124 GnRH signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
125 Graft-versus-host disease 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
126 Hematopoietic cell lineage 💬
1件: CD2 💬 Siplizumab 💬 Siplizumab 2件: 94, 95 💬
127 Hematopoietic cell lineage 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
128 Hematopoietic cell lineage 💬
1件: ITGA5 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
129 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Rituximab 💬 Rituximab 52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
130 Hematopoietic cell lineage 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
131 Hepatitis B 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
132 Hepatitis C 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
133 Hepatitis C 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
134 Hepatitis C 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
135 Hepatitis C 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
136 Hepatitis C 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
137 Hepatitis C 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
138 Hepatocellular carcinoma 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
139 Hepatocellular carcinoma 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
140 Herpes simplex virus 1 infection 💬
1件: ITGA5 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
141 Herpes simplex virus 1 infection 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
142 Herpes simplex virus 1 infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
143 HIF-1 signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
144 HIF-1 signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
145 Human cytomegalovirus infection 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
146 Human cytomegalovirus infection 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
147 Human cytomegalovirus infection 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
148 Human cytomegalovirus infection 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
149 Human cytomegalovirus infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
150 Human immunodeficiency virus 1 infection 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
151 Human immunodeficiency virus 1 infection 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
152 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
153 Human papillomavirus infection 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
154 Human papillomavirus infection 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
155 Human papillomavirus infection 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
156 Human papillomavirus infection 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
157 Human papillomavirus infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
158 Human T-cell leukemia virus 1 infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
159 Huntington disease 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
160 Huntington disease 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
161 Hypertrophic cardiomyopathy 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
162 Hypertrophic cardiomyopathy 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
163 Hypertrophic cardiomyopathy 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
164 IL-17 signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
165 Inflammatory bowel disease 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
166 Influenza A 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
167 Influenza A 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
168 Insulin resistance 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
169 Insulin resistance 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
170 Insulin resistance 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
171 Insulin resistance 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
172 Intestinal immune network for IgA production 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
173 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
174 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
175 Kaposi sarcoma-associated herpesvirus infection 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
176 Kaposi sarcoma-associated herpesvirus infection 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
177 Legionellosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
178 Leishmaniasis 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
179 Leishmaniasis 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
180 Leishmaniasis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
181 Leukocyte transendothelial migration 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
182 Leukocyte transendothelial migration 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
183 Lipid and atherosclerosis 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
184 Lipid and atherosclerosis 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
185 Lipid and atherosclerosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
186 Longevity regulating pathway 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
187 Longevity regulating pathway 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
188 Malaria 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
189 MAPK signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
190 MAPK signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
191 MAPK signaling pathway 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
192 MAPK signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
193 Melanoma 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
194 Melanoma 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
195 Melanoma 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
196 MicroRNAs in cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
197 MicroRNAs in cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
198 MicroRNAs in cancer 💬
1件: ITGA5 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
199 mTOR signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
200 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
201 Necroptosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
202 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Budesonide 💬 Budesonide 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
203 NF-kappa B signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
204 NOD-like receptor signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
205 Non-alcoholic fatty liver disease 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
206 Non-alcoholic fatty liver disease 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
207 Non-alcoholic fatty liver disease 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
208 Non-alcoholic fatty liver disease 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
209 Non-alcoholic fatty liver disease 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
210 Non-alcoholic fatty liver disease 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
211 Non-small cell lung cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
212 Non-small cell lung cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
213 Non-small cell lung cancer 💬
1件: RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
214 One carbon pool by folate 💬
1件: thyA 💬 Capecitabine 💬 Capecitabine 1件: 94 💬
215 Osteoclast differentiation 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
216 Osteoclast differentiation 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
217 Osteoclast differentiation 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
218 Oxytocin signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
219 Oxytocin signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
220 Pancreatic cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
221 Pancreatic cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
222 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
223 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
224 Pathogenic Escherichia coli infection 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
225 Pathogenic Escherichia coli infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
226 Pathways in cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
227 Pathways in cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
228 Pathways in cancer 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
229 Pathways in cancer 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
230 Pathways in cancer 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
231 Pathways in cancer 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
232 Pathways in cancer 💬
3件: PML, RARA, RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
233 Pathways of neurodegeneration - multiple diseases 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
234 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
235 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
236 Pertussis 💬
2件: ITGA5, ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
237 Pertussis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
238 Phagosome 💬
2件: ITGA5, ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
239 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
240 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
241 PI3K-Akt signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
242 PI3K-Akt signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
243 PI3K-Akt signaling pathway 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
244 PI3K-Akt signaling pathway 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
245 PI3K-Akt signaling pathway 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
246 Platelet activation 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
247 PPAR signaling pathway 💬
1件: NR1C1 💬 Bezafibrate 💬 Bezafibrate 8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
248 PPAR signaling pathway 💬
1件: NR1C1 💬 Elafibranor 💬 Elafibranor 2件: 93, 94 💬
249 PPAR signaling pathway 💬
1件: NR1C1 💬 Fenofibrate 💬 Fenofibrate 6件:  8 , 79, 93, 94, 97, 265 💬
250 PPAR signaling pathway 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
251 PPAR signaling pathway 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
252 Prion disease 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
253 Prostate cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
254 Prostate cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
255 Proteoglycans in cancer 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
256 Proteoglycans in cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
257 Proteoglycans in cancer 💬
2件: ITGA5, ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
258 Proteoglycans in cancer 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
259 Purine metabolism 💬
2件: IMPDH, IMPDH 💬 Mizoribine 💬 Mizoribine 8件: 46, 49, 51, 53, 66, 94, 222, 224 💬
260 Purine metabolism 💬
1件: RRM1 💬 Cladribine 💬 Cladribine 3件: 11, 13, 94 💬
261 Pyrimidine metabolism 💬
1件: DHODH 💬 Vidofludimus 💬 Vidofludimus 5件: 13, 46, 94, 96, 97 💬
262 Pyrimidine metabolism 💬
1件: DHODH 💬 Vidofludimus calcium 💬 Vidofludimus 5件: 13, 46, 94, 96, 97 💬
263 Pyrimidine metabolism 💬
1件: RRM1 💬 Cladribine 💬 Cladribine 3件: 11, 13, 94 💬
264 Pyrimidine metabolism 💬
1件: thyA 💬 Capecitabine 💬 Capecitabine 1件: 94 💬
265 Rap1 signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
266 Rap1 signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
267 Rap1 signaling pathway 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
268 Rap1 signaling pathway 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
269 Ras signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
270 Ras signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
271 Ras signaling pathway 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
272 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
273 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
274 Regulation of actin cytoskeleton 💬
1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
275 Regulation of actin cytoskeleton 💬
2件: ITGA4, ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
276 Regulation of actin cytoskeleton 💬
3件: ITGA5, ITGB1, ITGB6 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
277 Relaxin signaling pathway 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
278 Relaxin signaling pathway 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
279 Rheumatoid arthritis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
280 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
281 Salmonella infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
282 Shigellosis 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
283 Shigellosis 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
284 Shigellosis 💬
2件: ITGA5, ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
285 Shigellosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
286 Small cell lung cancer 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
287 Small cell lung cancer 💬
1件: RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
288 Sphingolipid signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
289 Systemic lupus erythematosus 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
290 T cell receptor signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
291 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Rosuvastatin calcium 💬 Rosuvastatin 13件:  6 , 18, 46, 49, 51, 56, 65, 79, 94, 96, 97, 271, 299 💬
292 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Rosuvastatin 💬 Rosuvastatin 13件:  6 , 18, 46, 49, 51, 56, 65, 79, 94, 96, 97, 271, 299 💬
293 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
294 TGF-beta signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
295 Th17 cell differentiation 💬
1件: RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
296 Thermogenesis 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
297 Thermogenesis 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
298 Thyroid cancer 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
299 Thyroid cancer 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
300 Tight junction 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
301 TNF signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
302 Toll-like receptor signaling pathway 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
303 Toxoplasmosis 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
304 Toxoplasmosis 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
305 Toxoplasmosis 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
306 Toxoplasmosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
307 Transcriptional misregulation in cancer 💬
1件: ITGB7 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
308 Transcriptional misregulation in cancer 💬
1件: NR1C3 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬
309 Transcriptional misregulation in cancer 💬
1件: NR1C3 💬 Seladelpar lysine 💬 Seladelpar 2件: 93, 94 💬
310 Transcriptional misregulation in cancer 💬
2件: PML, RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
311 Tuberculosis 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
312 Type I diabetes mellitus 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
313 Type II diabetes mellitus 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
314 Ubiquitin mediated proteolysis 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
315 Viral carcinogenesis 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
316 Viral carcinogenesis 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
317 Viral life cycle - HIV-1 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
318 Viral life cycle - HIV-1 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
319 Viral protein interaction with cytokine and cytokine receptor 💬
2件: CCR2, CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
320 Viral protein interaction with cytokine and cytokine receptor 💬
2件: CCR2, CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
321 Viral protein interaction with cytokine and cytokine receptor 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
322 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
323 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
324 Virion - Herpesvirus 💬
1件: ITGA5 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
325 Virion - Human immunodeficiency virus 💬
1件: CCR5 💬 Cenicriviroc 💬 Cenicriviroc 1件: 94 💬
326 Virion - Human immunodeficiency virus 💬
1件: CCR5 💬 Cenicriviroc mesylate 💬 Cenicriviroc 1件: 94 💬
327 Virion - Rotavirus 💬
1件: ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
328 Yersinia infection 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
329 Yersinia infection 💬
2件: ITGA5, ITGB1 💬 Bexotegrast 💬 Bexotegrast 1件: 94 💬
330 Yersinia infection 💬
1件: TNF 💬 Thalidomide 💬 Thalidomide 21件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬